Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children

August 1, 2024 updated by: JoAnna K. Leyenaar, Dartmouth-Hitchcock Medical Center
At a national level, emergency departments (EDs) serve as the portal of hospital admission for 75% of hospitalized children. The remainder occur via direct admission, defined as admission to hospital without first receiving care in the hospital's ED. The overall goals of this research are to: (i) implement pediatric direct admission systems at 3 hospitals, (ii) compare the timeliness of healthcare delivery for children who are admitted directly and through emergency departments, (iii) determine which patient populations achieve the greatest benefits from direct admission, and (iv) identify barriers and facilitators of successful implementation.

Study Overview

Detailed Description

The Specific Aims of this research are to: (i) Determine the effect of a pediatric direct admission system on timeliness of healthcare provision (the investigator's primary outcome), family experience of care, and rates of clinical deterioration compared to hospital admission beginning in the ED; (ii) Identify the pediatric populations and conditions that experience the greatest benefits from direct admission; and (iii) Through interviews with key informants, identify barriers to and facilitators of implementing standardized direct admission processes.

To achieve these Aims, a stepped-wedge cluster randomized controlled trial at three geographically diverse hospitals in the United States will be conducted, randomizing primary and urgent care practices in the hospitals' catchment area to cross over to the direct admission intervention at four time points. Linear models with random effects for clusters and time period fixed effects will be used to evaluate outcomes associated with the direct admission intervention. To examine for heterogeneity of treatment effects, interactions between direct admission and a priori-specified subgroups will be examined.

Study Type

Interventional

Enrollment (Actual)

1997

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43205
        • Nationwide Children's Hospital
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15224
        • UPMC Children's Hospital of Pittsburgh
    • Washington
      • Everett, Washington, United States, 98201
        • Providence Regional Medical Center - Everett

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

Child has one of the following presenting diagnoses:

  • gastroenteritis
  • dehydration
  • skin and soft tissue infection
  • urinary tract infection/pyelonephritis
  • pneumonia
  • viral infection not otherwise specified
  • influenza

Exclusion Criteria

Ineligible children include those:

  • with planned admissions (i.e., chemotherapy)
  • admitted to non-pediatric hospital medicine services (i.e., intensive care)
  • transferred from other hospitals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Direct Admission
Referring providers contact the hospital to arrange for a child to be admitted directly into the pediatric hospital medicine unit.
Process of pediatric admission is through admission directly into the pediatric hospital medicine unit
Active Comparator: ED Admission
Children initially present at the Emergency Department and are then admitted to the pediatric hospital medicine unit.
Process of pediatric admission is through the emergency department

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timeliness of Clinical Care - Initial Therapeutic Management
Time Frame: within 6 hours of hospital admission
Length of time from arrival at the hospital until time of first antibiotics, IV placement, fluid administration, or other medications
within 6 hours of hospital admission
Timeliness of Clinical Care - Initial Clinical Assessment
Time Frame: within 6 hours of hospital admission
Length of time from arrival at the hospital until first time when at least 3 vital signs were documented; if missing, time of initial brief nursing assessment
within 6 hours of hospital admission
Timeliness of Clinical Care - Initial Diagnostic Testing
Time Frame: within 6 hours of hospital admission
Length of time from arrival at the hospital until time of initial labs and/or imaging, including "standing orders" for diagnostic testing in emergency departments
within 6 hours of hospital admission

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Clinical Deterioration
Time Frame: within 6 hours of arrival on the inpatient unit
Transfer for pediatric intensive care or rapid response calls
within 6 hours of arrival on the inpatient unit
Pediatric Hospitalization Admission Survey of Experience (PHASE)
Time Frame: Within 72 hours of hospital admission
Standardized closed-ended survey questions regarding parent-reported experience of hospital admission with respect to the admission process, communication with families, communication between providers, and the hospital space; composite measure on 0-1 scale, with higher scores indicating better family experience
Within 72 hours of hospital admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: JoAnna K Leyenaar, MD, PhD, Dartmouth-Hitchcock Medical Center; Geisel School of Medicine at Dartmouth

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

April 30, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

December 6, 2019

First Submitted That Met QC Criteria

December 9, 2019

First Posted (Actual)

December 10, 2019

Study Record Updates

Last Update Posted (Actual)

October 21, 2024

Last Update Submitted That Met QC Criteria

August 1, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IHS-2018C2-12902-IC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospitalization

Clinical Trials on Direct admission

Subscribe